CytoReason
Business Services · 51-200 Employees
View Company Info for Free
Overview
Website
www.cytoreason.comRevenue
$17.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About CytoReason
CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical companies and uses it to simulate human diseases - tissue by tissue, cell by cell. With CytoReason's massive database and AI-led platform, pharma and biotech companies can identify new opportunities, shorten trial phases, reduce development costs, and increase the likelihood of approval.Explore more
CytoReason Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CytoReason your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CytoReason had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CytoReason
Funding: Get notified immidiatlly once CytoReason has new funding data
Earning: See what the market has to say on CytoReason recently announced quarterly report
CytoReason, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if CytoReason is spiking on competitors!
Check if CytoReason has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CytoReason launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at CytoReason
Find 3 more new buyers
Compare Similar Companies to CytoReason
Compare insights from companies similar to CytoReason, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$118.1M
201-500
Private
<$5M
2011
MB
Monica BhattGlobal Chief Human Resources Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
CytoReason is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CytoReason is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CytoReason.
CytoReason financials insights
Gather financial insights about CytoReason, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$80M
CytoReason Tech Stack
A closer look at the technologies used by CytoReason
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
CytoReason News & Media
CytoReason extends its collaboration with Sanofi to advance AI-driven drug discovery
This marks CytoReason's fifth commercial deal of 2025 and builds on its track record with half of the world's top twenty pharma companies, which have leveraged its technology across a range of programs. TEL AVIV, Israel, Jan. 9, 2026 /PRNewswire/ -- CytoReason, a leader in AI-powered...Israeli startup CytoReason raises $80M to expand AI model, open hub in Massachusetts
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.Israeli AI tech startup CytoReason raises $80M led by Nvidia and Pfizer to grow its AI drug discovery platform
CytoReason, an Israeli tech startup that uses AI to develop disease models, announced on Wednesday that it has secured $80 million in a private funding round to expand its AI drug discovery platform. The round was led by industry giants […] The post Israeli AI tech startup CytoReason raises $80M led by Nvidia and Pfizer to grow its AI drug discovery platform first appeared on Tech Startups.Nvidia makes bet in Israeli AI health tech start-up - Mobile World Live
The online communications hub for the global mobile industry
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CytoReason
Sign Up For FreeTo access detailed company insights
CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical companies and uses it to simulate human diseases - tissue by tissue, cell by cell. With CytoReason's massive database and AI-led platform, pharma and biotech companies can identify new opportunities, shorten... Read More
